FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004013007> ?p ?o ?g. }

• W3004013007 endingPage "3493" @default.
• W3004013007 startingPage "3482" @default.
• W3004013007 abstract "Tumor hypoxia is known to be one of the vital factors that aggravate tumor resistance to radiation therapy (RT) in which oxygen plays a critical role in tumor destruction. Herein, we synthesize a simple nanoradiosensitizer based on ultrathin BiO2–x nanosheets (NSs) modified with Tween 20 (T-BiO2–x NSs) to overcome the hypoxia-induced radioresistance as well as increase the efficacy of RT. On the one hand, bismuth as a high-Z element can effectively enhance the sensitivity of RT by depositing a higher radiation dose in tumors. The semiconductor property also endows its photocatalytic ability to produce extra reactive oxygen species (ROS) by reaction with the surrounding water. On the other hand, the defect-abundant BiO2–x NSs are also found to decompose the highly expressed hydrogen peroxide (H2O2) at the tumor site into oxygen (O2) for combating hypoxia. Both in vitro and in vivo experiments indicate that the as-prepared T-BiO2–x NSs could effectively inhibit tumor growth with X-ray irradiation. Our work thus provides a simple nanoradiosensitizer with multifunctionalities for increasing the RT efficacy while alleviating tumor hypoxia at the same time." @default.
• W3004013007 created "2020-02-07" @default.
• W3004013007 creator A5007951489 @default.
• W3004013007 creator A5012770174 @default.
• W3004013007 creator A5015799036 @default.
• W3004013007 creator A5024961053 @default.
• W3004013007 creator A5053113201 @default.
• W3004013007 creator A5054199475 @default.
• W3004013007 creator A5057852508 @default.
• W3004013007 creator A5060005951 @default.
• W3004013007 creator A5072315367 @default.
• W3004013007 creator A5076155990 @default.
• W3004013007 date "2020-01-28" @default.
• W3004013007 modified "2023-10-17" @default.
• W3004013007 title "BiO_2–<i>x</i> Nanosheets as Radiosensitizers with Catalase-Like Activity for Hypoxia Alleviation and Enhancement of the Radiotherapy of Tumors" @default.
• W3004013007 cites W1507021713 @default.
• W3004013007 cites W1912124796 @default.
• W3004013007 cites W1976652877 @default.
• W3004013007 cites W2025033391 @default.
• W3004013007 cites W2046325076 @default.
• W3004013007 cites W2052874737 @default.
• W3004013007 cites W2065634626 @default.
• W3004013007 cites W2075647502 @default.
• W3004013007 cites W2076810252 @default.
• W3004013007 cites W2080815560 @default.
• W3004013007 cites W2081559176 @default.
• W3004013007 cites W2093424661 @default.
• W3004013007 cites W2095469029 @default.
• W3004013007 cites W2096694929 @default.
• W3004013007 cites W2100782933 @default.
• W3004013007 cites W2109294354 @default.
• W3004013007 cites W2117878645 @default.
• W3004013007 cites W2120600243 @default.
• W3004013007 cites W2132834292 @default.
• W3004013007 cites W2142619483 @default.
• W3004013007 cites W2144664554 @default.
• W3004013007 cites W2170590696 @default.
• W3004013007 cites W2209394102 @default.
• W3004013007 cites W2256492013 @default.
• W3004013007 cites W2264449908 @default.
• W3004013007 cites W2291205197 @default.
• W3004013007 cites W2305745682 @default.
• W3004013007 cites W2309569522 @default.
• W3004013007 cites W2334468728 @default.
• W3004013007 cites W2412969323 @default.
• W3004013007 cites W2417259144 @default.
• W3004013007 cites W2504396398 @default.
• W3004013007 cites W2530681900 @default.
• W3004013007 cites W2543764929 @default.
• W3004013007 cites W2549648393 @default.
• W3004013007 cites W2587143085 @default.
• W3004013007 cites W2632077510 @default.
• W3004013007 cites W2734441486 @default.
• W3004013007 cites W2737866071 @default.
• W3004013007 cites W2738239402 @default.
• W3004013007 cites W2753428907 @default.
• W3004013007 cites W2766567990 @default.
• W3004013007 cites W2769879759 @default.
• W3004013007 cites W2791785017 @default.
• W3004013007 cites W2792610293 @default.
• W3004013007 cites W2805886198 @default.
• W3004013007 cites W2886967196 @default.
• W3004013007 cites W2888829434 @default.
• W3004013007 cites W2890551917 @default.
• W3004013007 cites W2893436613 @default.
• W3004013007 cites W2897602119 @default.
• W3004013007 cites W2907154866 @default.
• W3004013007 cites W2907447350 @default.
• W3004013007 cites W2908838385 @default.
• W3004013007 cites W2914976666 @default.
• W3004013007 cites W2917515785 @default.
• W3004013007 cites W2921870058 @default.
• W3004013007 cites W2922650658 @default.
• W3004013007 cites W2937420078 @default.
• W3004013007 cites W2937682709 @default.
• W3004013007 cites W2940534898 @default.
• W3004013007 cites W2940955531 @default.
• W3004013007 cites W2943029133 @default.
• W3004013007 cites W2944521716 @default.
• W3004013007 cites W2948716135 @default.
• W3004013007 cites W2950056753 @default.
• W3004013007 cites W2959036110 @default.
• W3004013007 cites W2978209500 @default.
• W3004013007 cites W2979410128 @default.
• W3004013007 cites W2981144406 @default.
• W3004013007 cites W4211008944 @default.
• W3004013007 cites W4298306887 @default.
• W3004013007 doi "https://doi.org/10.1021/acs.inorgchem.9b03280" @default.
• W3004013007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31990186" @default.
• W3004013007 hasPublicationYear "2020" @default.
• W3004013007 type Work @default.
• W3004013007 sameAs 3004013007 @default.
• W3004013007 citedByCount "56" @default.
• W3004013007 countsByYear W30040130072020 @default.
• W3004013007 countsByYear W30040130072021 @default.
• W3004013007 countsByYear W30040130072022 @default.
• W3004013007 countsByYear W30040130072023 @default.
• W3004013007 crossrefType "journal-article" @default.

• next